Schonfeld Strategic Advisors’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-69,940
| Closed | -$695K | – | 2893 |
|
|
2022
Q3 | $695K | Hold |
69,940
| – | – | 0.01% | 1497 |
|
|
2022
Q2 | $689K | Buy |
69,940
+33,806
| +94% | +$333K | 0.01% | 1124 |
|
|
2022
Q1 | $354K | Buy |
36,134
+1,865
| +5% | +$18.3K | ﹤0.01% | 1518 |
|
|
2021
Q4 | $339K | Sell |
34,269
-20,731
| -38% | -$205K | ﹤0.01% | 1395 |
|
|
2021
Q3 | $546K | Buy |
55,000
+22,972
| +72% | +$228K | 0.01% | 1144 |
|
|
2021
Q2 | $311K | Buy |
32,028
+14,005
| +78% | +$136K | ﹤0.01% | 1409 |
|
|
2021
Q1 | $174K | Buy |
+18,023
| New | +$174K | ﹤0.01% | 1514 |
|